Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × OTHER × Engineering × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1

Interventions

Drug Therapy 89 Cisplatin 84 Carboplatin 72 Radiotherapy 69 Bevacizumab 65 Oxaliplatin 64 Gemcitabine 58 Capecitabine 56 pembrolizumab 55 Cyclophosphamide 55 toripalimab 51 tislelizumab 51 Paclitaxel 51 sintilimab 44 Surgical Procedures, Operative 44 Fluorouracil 43 Specimen Handling 40 130-nm albumin-bound paclitaxel 39 Magnetic Resonance Spectroscopy 36 anlotinib 34 Immune Checkpoint Inhibitors 34 Radiosurgery 31 Blood Specimen Collection 30 lenvatinib 29 Standard of Care 28 Leucovorin 28 Docetaxel 27 Biopsy 26 fludarabine 25 apatinib 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07366658 2026-01-26

NEUK203-13

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 1 Not yet recruiting

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡